UK markets closed

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.17-0.40 (-2.28%)
At close: 04:00PM EDT
17.25 +0.08 (+0.47%)
After hours: 04:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
130,521
130,521
85,618
43,584
9,100
Selling general and administrative
75,543
75,543
61,291
29,159
4,682
Total operating expenses
206,064
206,064
146,909
72,743
13,782
Operating income or loss
-206,064
-206,064
-146,909
-72,743
-13,782
Interest expense
-
-
-
-
30
Total other income/expenses net
17,147
17,147
4,728
-11
-30,031
Income before tax
-188,917
-188,917
-142,181
-72,754
-43,843
Income from continuing operations
-188,917
-188,917
-142,181
-72,754
-43,843
Net income
-188,917
-188,917
-142,181
-70,645
-40,507
Net income available to common shareholders
-188,917
-188,917
-142,181
-170,639
-40,507
Basic EPS
-2.29
-
-2.17
-4.62
-0.96
Diluted EPS
-2.29
-
-2.17
-4.62
-0.96
Basic average shares
76,086
-
65,467
36,961
42,031
Diluted average shares
76,086
-
65,467
36,961
42,031